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ABSTRACT
Objectives: Adequate folate intake constitutes a significant problem in the periconceptional period and early pregnancy 
but can be achieved by folic acid (FA) supplementation. Low intake of folate may cause numerous negative effects on the 
pregnancy outcome, including recurrent miscarriage, preeclampsia, fetal hypotrophy, premature delivery, premature pla-
cental abruption, and intrauterine fetal death. The aim of the study was to evaluate factors determining FA supplementation 
in the population of Polish women before and during pregnancy.
Material and methods: The study group consisted of 257 women hospitalized postpartum at the Division of Perinatology 
and Women’s Diseases, Poznan University of Medical Sciences, Poland. We evaluated folic acid intake considering selected 
demographic data. A structured questionnaire was used to evaluate folic acid intake before and during pregnancy of the 
investigated women. 
Results: The vast majority of the investigated women (89.1%) took FA during pregnancy. During the pre-pregnancy period, 
a statistically significantly higher supplementation of folic acid was observed among women with the monthly income level 
of  > 5000 PLN (p = 0.03), and among women who planned their pregnancy as compared to women who did not plan their 
pregnancy (p < 0.001). During pregnancy, these differences disappeared. A statistically significantly higher number of 
secundi- and multiparas did not take FA during pregnancy as compared to primiparas (p = 0.008). No correlation between 
cigarette smoking and FA intake was observed.
Conclusions: Our analysis showed that FA intake increased (by 36.2%) during pregnancy as compared to the pre-pregnancy 
period, and depended on income, parity, and pregnancy planning.
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INTRODUCTION
Pregnancy is associated with higher demand for nutri-
tional compounds due to physiological changes occurring 
in the body of the woman and demands of the fetus. Proper 
amount of vitamins and minerals, as well as adequate caloric 
intake, are extremely important in this period and lead to 
proper weight gain and adequate fetal development. On 
the contrary, poor level of minerals and vitamins might 
significantly negatively affect the fetus. Thus, it is vital to sup-
plement the diet of a pregnant woman especially with folate, 
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iron, vitamin D, iodine and polyunsaturated fatty acids in 
order to prevent maternal and fetal complications [1–3].
Folic acid (FA), chemically pteroylglutamic acid, belongs 
to B-group vitamins and consists of three elements: pteridi-
ne (2-amino-4 hydroxy-6-methylpteridine), p-aminobenzoic 
acid (PABA), and glutamine acid. FA is synthesized by some 
plants, bacteria, and yeast. It regulates growth, division and 
cell function, preserving genetic material, and contributes 
to methylation processes in numerous reactions in the hu-
man body. It improves psychological health and nervous 
system function, prevents anemia and development of se-
veral cancers, as well as plays an important role in proper 
liver, stomach and intestine function [4, 5].
Intake of appropriate dosage of folate in the periconcep-
tional period and early pregnancy remains a significant pro-
blem. Proper folate level in pregnant women is achieved by 
FA supplementation during the periconceptional period and 
daily administration during pregnancy. In Poland, daily recom-
mended doses of FA in pregnant and breastfeeding women 
range between 400–800 μg and 450–530 μg, respectively. 
Since the 60’s of the twentieth century, studies have shown that 
regular FA supplementation decreases the risk of neural tube 
defects in families affected by this complication. Observational 
and randomized studies from the last forty years confirmed 
the significant role of FA supplementation in decreasing birth 
defects (neural tube defects, orofacial cleft, hearts defects, and 
Down syndrome) [6]. Numerous studies have reported that 
women with insufficient folate intake in the periconceptional 
period and first weeks of pregnancy are at an increased risk of 
giving birth to infants with neural tube defects, although the 
exact mechanism responsible for this effect remains unclear 
[7–9]. Low intake of folate could also have many negative ef-
fects on pregnancy outcome, including recurrent miscarriage, 
preeclampsia, fetal hypotrophy, premature delivery, premature 
placental abruption, and intrauterine fetal death [10, 2, 11].
Taking into consideration the necessity of preserving 
adequate level of folate in women of childbearing age, and 
additionally the augmentation of folate demand in pregnant 
women, FA supplementation seems to be the appropriate 
preventive measure to improve pregnancy outcome. There-
fore, food fortification with FA was started in several coun-
tries such as the United States, Canada, Chile, and Australia, 
where a significant decrease in the incidence of fetal neural 
tube defects was observed [12]. In Poland, the Prevention of 
Primordial Neural Tube Defects Program has been realized 
since 1997. It was designed to promote FA supplementation in 
women of childbearing potential and raise awareness about 
the possibility of preventing neural tube defects among the 
general public. National Health Programs, developed during 
2004–2013 and 2007–2015, advertise the necessity to prevent 
neural tube defects [13]. However, there is still a need for fur-
ther research on the intake of FA by women of childbearing 
age, as it would allow to assess the frequency of neural tube 
defects in the context of active prevention. Additionally, the 
multiplicity of factors affecting the awareness of women 
and conditioning adequate FA supplementation before and 
during pregnancy remains an interesting issue. 
The aim of our study was to evaluate demographic fac-
tors which determine FA supplementation in the population 
of Polish women before and during pregnancy.
MATERIAL AND METHODS
Patients
A total of 320 women hospitalized postpartum at the 
Division of Perinatology and Women’s Diseases, Poznan Uni-
versity of Medical Sciences, Poland, were recruited for the 
study. Out of them, 43 failed to complete the interview and 
20 refused to participate after the initial agreement, so they 
were disqualified from the study. In the end, the study group 
consisted of 257 women. The investigation was conducted 
between January 2014 and December 2014. All participants 
were informed about the goal of the study and gave their 
written consent. Local Ethics Committee approved of the 
study design. All women had singleton pregnancies. Sub-
jects with nervous system diseases, psychiatric and cognitive 
complications were excluded from the study. Women with 
several obstetric pathologies (preeclampsia, fetal hypotrophy, 
stillbirths, recurrent miscarriage, preterm delivery), as well as 
women who delivered a defected child also were disqualified.
Questionnaire
A structured questionnaire was used to evaluate folic 
acid intake before and during pregnancy of the investigated 
women. The interview was completed between 48–72 ho-
urs postpartum. The questionnaire consisted of 30 questions 
divided into categories: demographic data, clinical data, per-
inatal care, dietary habits, use of drugs and supplements. The 
following demographic data were collected: age, family sta-
tus (married, widow, divorced, domestic partnership, single), 
area of residence (urban, rural), level of education (primary, 
vocational, secondary, bachelor’s and master’s degrees), and 
monthly income (< 2000 PLN, 2000–5000 PLN, > 5000 PLN). 
Components of perinatal care included wanted or unwanted 
pregnancy, parity, gestational age at delivery, beginning of 
perinatal care, total number of prenatal visits. Dietary habits 
and drugs included questions about type of diet and smoking 
(before and during pregnancy). Each patient was questioned 
about the use of folic acid in detail.
Statistical analyses
All statistical analysis were performed with R software 
(version 3.4.3), at the 5% significance level. T-test was used 
in case of parametric variables (age, weight), Wilcoxon test 
was used for education. Chi square test or Fisher exact test 
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(used whenever expected cell value was < 5) was used to 
analyze the association between categorical variables.
RESULTS
Characteristics of the study participants
Mean age of the 257 participants was 31.0 years (ran-
ge: 18–42 years, 9.7% between 18–25 years, 75.9% between 
26–35 years, and 14.4% over 35 years of age). The 55.3%, of the 
studied population were residents of urban areas, while 44.7% 
lived in rural areas. All participants had formal education: 
master’s degree (69.3%), bachelor’s degree (3.9%), secondary 
(19.8%), vocational (5.1%), and primary (1.9%). As far as marital 
status is concerned, most of the investigated women were 
married (82.9%), with the remaining 11.3% were unmarried 
but living with a partner, 4.3% were single, 1.5% were divorced, 
there were no widows in the studied groups. 84,0% of qualified 
women has planned their pregnancy. Most of the patients in 
our study were mothers of one child (149 patients 58.0%), whi-
le 108 (42.0%) patients had 2 or more children (median 1 range 
1–5). A monthly household income of < 2000 PLN, between 
2000–5000 PLN, and > 5000 PLN was declared by 34.2%, 54.5% 
and 11.3% of the respondents, respectively. A normal diet was 
reported by 84.1% of the women, whereas vegetarian and 
meat predominated diet declared the same amount (1.9% 
each) of participants. Smoking before and during pregnancy 
was reported by 18.3% and 5.5% of the patients, respectively. 
Mean weight gain in pregnancy was about 14 kg. All data is 
presented in Table 1.
Relationship between demographic parameters 
and folic acid supplementation
Our analysis showed that 136 women (52.9%) were ta-
king folic acid before pregnancy at a dose of 0.4–0.8 mg, 
while 121 women (47.1%) did not supplement their diet with 
folic acid at all. During pregnancy, most of the investigated 
women (89.1%) were taking FA. There were no observed age 
differences between the groups of takers and non-takers of 
FA (p = 0.98). Compared to the pre-pregnancy period, the 
intake of FA increased by 36.2% during pregnancy. During 
pregnancy, 9 women in study group (9/257, 3.5%) took FA at 
an increased dose of 5.0 mg because of having the previous 
child with neural tube defects (2 women) and recurrent 
miscarriages in anamnesis (7 women).
Any statistical differences between the groups of takers 
and non-takers of FA connected to area of residence, educa-
tional level, marital status, maternal body weight, maternal 
diet, smoking status as well as folic acid intake before and 
during pregnancy have been observed.
Our analysis showed that most of women who did not 
take folic acid during pregnancy had a monthly income 
of below 2.000 PLN. In the group with high monthly in-
come (> 5000 PLN), more women were taking FA before 
pregnancy as compared to the lower-income group 
(< 2000 PLN/month). The difference was statistically signifi-
cant (p = 0.03). However, this difference disappeared during 
pregnancy because most women in both groups (with high 
and low income) took FA supplementation.
The clear majority (89.1%, 229/257) of women accepted 
FA intake during pregnancy. Interestingly, a statistically signifi-
cantly lower FA consumption was found among secundi- and 
multiparous as compared to primiparous women (p = 0.008).
In next step we assessed the consumption of folic acid 
during pregnancy among Polish postpartum women and 
analyzed the difference of folic acid supplementation be-
tween planned and unplanned pregnancies. As might be 
Table 1. Background characteristics of participants (n = 257)
Characteristics
Maternal age (years), mean ± SD 
Height [cm], mean ± SD 
Weight before pregnancy [kg], mean ± SD 
Weight during pregnancy [kg], mean ± SD 
Number of children, median (range)
31.0 ± 4.4
166.6 ± 11.0
61.9 ± 11.0
75.9 ± 12.5
1 (1–5)
Maternal age groups, n (%)
18–25 years
26–35 years
> 35 years
25 (9.7)
195 (75.9)
37 (14.4)
Area of residence, n (%)
urban
rural
142 (55.3)
115 (44.7)
Educational level, n (%)
primary 
vocational
secondary
bachelor’s degree
master’s degree
5 (1.9)
13 (5.1)
51 (19.8)
10 (3.9)
178 (69.3)
Marital status, n (%)
widowed
divorced
married
living with partner
single
0 (0.0)
4 (1.5)
213 (82.9)
29 (11.3)
11 (4.3)
Planning of pregnancy, n (%) 
Planned pregnancy
Unplanned pregnancy
216 (84.0)
41 (16.0)
Household income (PLN), n (%)
< 2000 
2000–5000 
> 5000
88 (34.2)
140 (54.5)
29 (11.3)
Diet, n (%)
vegetarian
meat predominance
standard
other
5 (1.9)
5 (1.9)
216 (84.1)
31 (12.1)
Folic acid intake, n (%)
before pregnancy (yes/no)
during pregnancy (yes/no)
136 (52.9)/121 (47.1)
229 (89.1)/28 (10.9)
Smoking, n (%)
before pregnancy (yes/no)
during pregnancy (yes/no)
47 (18.3)/210 (81.7)
14 (5.5)/243 (94.5)
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expected, a statistically significantly higher percentage of FA 
supplementation before pregnancy was observed among 
women who planned their pregnancy than among those 
whose pregnancy was not planned (p < 0.001). In the plan-
ned pregnancy group 8.2% (n = 21) of women reported not 
taking folic acid during pregnancy, and in the unplanned 
pregnancy group only 2.7% of women (n = 7).
Relationship between statistically significant demogra-
phic parameters of folic acid takers and non-takers, before 
and during pregnancy is showed in Figure 1 and on Table 2.
Table 2. The frequency distribution of the variables concerning the relationship between demographic parameters and folic acid dose
Dose
FA supplementation before pregnancy FA supplementation during pregnancy
Not taken 0.4–0.8 mg 5.0 mg Not taken 0.4–0.8 mg 5.0 mg
Household income (in PLN)
n = 257
< 2000 50 (19.5) 38 (14.8) 0 (0.00) 15 (5.8) 70 (27.2) 3 (1.2)
2000–5000 62 (24.1) 78 (30.3) 0 (0.00) 12 (4.7) 124 (48.3) 4 (1.5)
> 5000 9 (3.5) 20 (7.8) 0 (0.00) 1 (0.4) 26 (10.1) 2 (0.8)
p = 0.03 p = 0.12
Parity
n = 257
< 2 66 (25.7) 83 (32.3) 0 (0.00) 9 (3.5) 133 (51.7) 7 (2.7)
≥ 2 55 (21.4) 53 (20.6) 0 (0.00) 19 (7.4) 75 (33.9) 2 (0.8)
p = 0.31 p = 0.008
Planning of pregnancy 
n = 257
Planned 87 (33.9) 130 (50.6) 0 (0.00) 21 (8.2) 190 (73.9) 6 (2.3)
Unplanned 34 (13.2) 6 (2.3) 0 (0.00) 7 (2.7) 30 (11.7) 3 (1.2)
p < 0.001 p = 0.08
0% 20% 40% 60% 80% 100% 0% 20% 40% 60% 80% 100%
0% 20% 40% 60% 80% 100% 0% 20% 40% 60% 80% 100%
0% 20% 40% 60% 80% 100% 0% 20% 40% 60% 80% 100%
Folic acid before pregnancy
Not taken
Houehold income (in PLN)
Parity
Planing of pregnancy
Taken
< 2000
< 2
≥ 2
Planing
Not planing
2000–5000
> 5000
Not taken Taken
Folic acid during pregnancy
Figure 1. Relationship between demographic parameters (household income, parity, and pregnancy planning) of folic acid takers and 
non-takers, before and during pregnancy
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DISCUSSION
In pregnancy, much attention is paid to sufficient folate 
supplementation due to the fact that daily diet does not pro-
vide adequate amounts of folate as well as the level of stored 
folate is rapidly reduced. On the other hand, the importance 
of folate and choline supplementation is unquestionable as 
its substances play a significant role in prevention of many 
obstetrical complications especially neural tube defects 
and Down syndrome [14–16]. Additionally, assumption 
of Developmental Origins of Health and Disease (DOHaD) 
hypothesis was shown that folate has large influence on 
public health [17–19]. Consider the above mentioned many 
countries decided to initiate FA fortification programs and 
simultaneously recommended the folate intake before and 
during pregnancy [20].
Lack of reliable information about nutritional habits as 
well as differences in nutrient intake in women of childbe-
aring age and during pregnancy have been observed worl-
dwide. Also, research correlating lifestyle, socioeconomic, 
demographic and dietary factors with dietary supplements 
are very poor. 
One of the first studies concerning the FA reception has 
shown that only 7.5% of women started supplementation 
at least four weeks prior to conception or pregnancy. Ad-
ditionally, it reported that FA was taken by only 52.2% of 
pregnant women. All of these women had at least secon-
dary education [21]. In our research 52.9% women were 
taking FA before pregnancy and during pregnancy 85.6% 
women were supplemented FA. In our study, most women 
were supplemented by the dose 0.4–0.8 mg FA, only few 
of investigated patients were taking 5 mg FA (patients with 
a history of pregnancy complicated by neural tube defects 
in the fetus).
In our study, women aged 25–35 years constituted the 
largest group of pregnant subjects, while the number of 
women aged over 35 years exceeded the number of women 
aged less than 25 years by two-fold, there were no pregnant 
women of < 18 years of age. Compared to a study conducted 
by Popa et al., similar age distribution of pregnant women 
was reported [22].
Income was an interesting factor influencing pre-pre-
gnancy FA supplementation. We have shown that more 
women were taking FA in the group with a monthly inco-
me of > 5000 PLN compared to the lower-income groups 
(p = 0.029). Forster et al. in the study in population of Au-
stralian women, indicated that one of the important factor 
associated with an increased risk of poor FA intake was the 
low income (≤ $ 30,000 AUD, OR = 2.85) [23].
There is a surprising relationship between FA intake 
during pregnancy and parity. Our study showed that FA 
intake is lower among secundi- and multiparous women as 
compared to primiparous (p = 0.008). Popa et al., observed 
a similar dependence, 52.6% of primi- and secundiparas 
were taking FA as compared to only 26.8% of multiparas 
[22]. Forster et al., also noted higher rates of multiparas 
who did not take FA as compared to primiparas (adjusted 
OR = 1.89) [23]. Their results may suggest that absence of 
FA supplementation does not necessarily result from lack 
of knowledge about its role but may be a conscious choice 
of the woman.
Our findings on the relationship between FA intake 
and pregnancy planning are consistent with studies con-
ducted in other countries. The number of subjects who did 
not plan their pregnancy is significantly higher (p = 0.09) 
among women who did not take FA before pregnancy. 
Periconceptional FA intake was more likely to occur among 
Korean women who planned their pregnancy or who were 
aware of the protective effects of FA during pregnancy [24]. 
In a cross-sectional study on a sample of 400 pregnant 
women, Popa et al., noted that 49.9% of FA-takers wanted 
pregnancy, as compared to 30% of FA takers with unwan-
ted pregnancy. Some authors observed that pregnancy 
planning was associated with a healthier lifestyle but there 
are still many women who could improve their lifestyle in 
connection to pregnancy.
We did not demonstrate an association between folate 
intake and type of diet in women before and during pre-
gnancy. Meanwhile, the literature data suggest that long-
-term high consumption of vegetables leads to improved 
folate status and may reduce the risk of folate deficien-
cy during pregnancy. In addition, the intake of vitamin B 
12 results in improved folate status among people using 
a vegetarian diet [25].
In our study, most women took a dose of 0.4– 
–0.8 mg FA (before and during pregnancy). High doses of FA 
(> 5 mg/24 hours) are recommended for women who expe-
rienced complications in previous pregnancies, i.e. with 
history of neural tube defects in the fetus. Additionally, we 
shown the greater FA intake during pregnancy as compared 
to the pre-pregnancy period. In a study conducted by Chatzi 
et al., 68% of the investigated women were taking < 5 mg FA 
daily, while 24% reported higher doses of FA (> 5 mg/24 ho-
urs), and 8% denied folic acid supplementation in early 
pregnancy. Doses of FA supplementation of > 5 mg/24 ho-
urs were not associated with an additional increase in the 
neurodevelopmental scales. Women with daily FA intakes 
of 5 mg were more likely to take one daily dose of supple-
mental folic acid, while women with higher intakes reported 
more than one daily dose [26].
Based on above-mentioned findings, it seems safe to 
conclude that in investigated group of Polish women FA sup-
plementation depends on several sociodemographic factors 
such as household income, parity, and pregnancy planning. 
On the other hand, according to some authors, nutritional 
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knowledge seems to be significantly associated with the 
intake of dietary supplements, regardless of the frequency 
of prenatal visits or sociodemographic characteristics [22].
CONCLUSIONS
1. FA intake increases during pregnancy as compared to 
the pre-pregnancy period what shown that pregnant 
women seem to be aware of potential complications 
caused by an inadequate amount of folate.
2. Women with better economic status, fewer children and 
those planning pregnancies are more likely to take FA 
supplementation.
3. No relationship between diet, age, cigarette smoking, 
body mass, and FA intake has been observed in the 
studied population of women.
4. Further studies concerning also the role of physicians 
and midwifes are needed in order to elucidate factors 
influencing the awareness about FA intake in women of 
childbearing age and during pregnancy.
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